a public good project by the
Synthesis
Company
of California

© 2026

Correction: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody | doi.page

0 citations

Google Scholar doi.org

Correction: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

Nature Communications·2013·Vol. 4(1)

Citations Over TimeTop 1% of 2013 papers

Alexander D. Douglas, Andrew R. Williams, Joseph J. Illingworth, Gathoni Kamuyu, Sumi Biswas, Anna L. Goodman, David Wyllie, Cécile Crosnier, Kazutoyo Miura, Gavin J. Wright, Carole A. Long, Faith Osier, Kevin Marsh, Alison Turner, Adrian V. S. Hill, Simon J. Draper

Related Papers

→ Intraleucocytic malaria pigment and clinical severity of malaria in children(1998)110 cited
→ Diagnosis and treatment of imported and odyssean malaria(2014)3 cited
Hearing loss: a possible consequence of malaria.(1995)
ANALYSIS OF MALARIA EPIDEMIC BEFORE AND AFTER ERADICATION OF MALARIA IN TIANDENG COUNTY IN GUANGXI FROM 1980-2008(2011)
→ Single dose of small molecule cures malaria in mice(2021)